According to a new analysis, most pharmaceutical companies are not disclosing full details regarding FDA drug rejections – leaving patients and practitioners in the dark. Should pharmaceutical companies practice more transparency? Should the FDA change its regulations? Read more here. (Source: Ed Silverman, the Wall Street Journal, 6/15/15)
You are here: / / Why Are Drug Makers Hiding Reasons Behind Drug Rejections?